Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis
Open Access
- 2 September 2025
- journal article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 47 (1) , 52-74
Abstract
One of the major metabolic functions of glucocorticoids (GC) is to maintain circulating glucose levels during stress, as glucose is the preferred energy source for the brain. Because of their potent anti-inflammatory and immune modulatory activities, GC are frequently used to treat inflammatory and autoimmune diseases. Chronic GC exposure, which can be a result of long-term GC pharmacotherapy and prolonged stress, however, causes undesired adverse effects that include hyperglycemia and insulin resistance. These adverse effects limit the application of GC therapy. GC act through an intracellular GC receptor (GR), a transcriptional regulator, to modulate the transcriptional rate of specific genes to exert physiological responses. The liver is a major target tissue of GC to modulate glucose homeostasis. In this review, we discuss the mechanisms of GR-activated transcription of genes involved in glucose metabolism and how hepatic GR primary target genes participate in the regulation of insulin sensitivity and glucose homeostasis. Transcriptional coregulators involved in GR-regulated transcription of glucose metabolism genes and signaling pathways specifically activated upon chronic GC exposure to induce glucose disorders are introduced. Metabolic profiles of liver-specific GR knockout mice are also reviewed. Finally, individual-specific GC responses and mechanisms underlying these phenomena are discussed. Overall, more extensive studies of the mechanisms of GR-regulated hepatic glucose homeostasis not only will expand our knowledge of the regulation of metabolic homeostasis but are also critical for developing improved GC pharmacotherapy and novel approaches to tackle metabolic disorders by targeting GR.Keywords
Funding Information
- National Institutes of Health (R01 DK113019)
- National Institutes of Health (DK124866)
- National Institutes of Health (DK131194)
- UCSF Liver Center (P30 DK026743)
This publication has 273 references indexed in Scilit:
- Regulation of gene expression of rat skeletal muscle/liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Isolation and characterization of a glucocorticoid response element in the first intron of the gene.Journal of Biological Chemistry, 1992
- HORMONE RESPONSE DOMAINS IN GENE TRANSCRIPTIONAnnual Review of Biochemistry, 1992
- In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factorCell, 1991
- The functional significance of biochemical alterations in streptozotocin-induced diabetesPhysiology & Behavior, 1991
- Chronic Streptozotocin Diabetes in Rats Facilitates the Acute Stress Response without Altering Pituitary or Adrenal Responsiveness to Secretagogues*Endocrinology, 1991
- Regulatory crosstalk at composite response elementsTrends in Biochemical Sciences, 1991
- Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene.Molecular and Cellular Biology, 1990
- Glucocorticoid Regulation of Hepatic 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Gene ExpressionJournal of Biological Chemistry, 1989
- Two remote glucocorticoid responsive units interact cooperatively to promote glucocorticoid induction of rat tyrosine aminotransferase gene expressionNucleic Acids Research, 1989
- Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase geneCell, 1987